Financials data is unavailable for this security.
View more
Year on year Allgens Medical Technology Co Ltd 's revenues fell -7.68% from 245.31m to 226.48m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 95.22m to 54.23m, a -43.04% decrease.
| Gross margin | 73.87% |
|---|---|
| Net profit margin | 0.19% |
| Operating margin | 1.37% |
| Return on assets | 0.02% |
|---|---|
| Return on equity | 0.37% |
| Return on investment | 0.02% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Allgens Medical Technology Co Ltd fell by 98.62m. However, the company earned 51.68m from its operations for a Cash Flow Margin of 22.82%. In addition the company used 118.08m on investing activities and also paid 32.22m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 10.49 |
|---|---|
| Tangible book value per share | 10.12 |
More ▼
Balance sheet in CNYView more
| Current ratio | 25.10 |
|---|---|
| Quick ratio | 24.27 |
| Total debt/total equity | 0.0349 |
|---|---|
| Total debt/total capital | 0.0333 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -43.92% and -43.04%, respectively. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 159.11% |
| EPS growth(5 years) | 10.46 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -94.48 |
More ▼
